Can CRISPR And These 3 Small Biotechs Cure 10,000 Diseases? [Investor's Business Daily]
CELGENE (CELG)
Last celgene earnings: 10/31 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.celgene.com
Company Research
Source: Investors Business Daily
Technology Related news 1/23/2018 Analysts and investors were more bullish Tuesday on Celgene following its announcement Monday that it would acquire Juno. Why Celgene's Rumored Acquisition Of Juno Actually Makes Sense Juno Therapeutics Stock Rockets On Report That Celgene Is In Buyout Talks Stocks Showing Market Leadership: CRISPR Therapeutics Earns 92 RS Rating Christmas Comes Early For These 5 Biotechnology Stocks Q&A: Vertex Chief Talks About Company's 'Transformational Year' Editas Medicine Joins Elite Club Of Stocks With RS Ratings Over 90 This Biotech Stock Seen As Cheapest Among Rivals In Cancer Drugs Nasdaq Marks 4th Straight Gain; Tesla Breaks Out Over Trend Line Imagine editing one gene and curing a debilitating disease. Three small biotech companies with combined annual sales of less than $50 million — Crispr Therapeutics ( CRSP ), Intellia Therapeutics ( NTLA ) and Editas Medicine ( EDIT ) — say that soon could be a reality.
Show less
Read more
Impact Snapshot
Event Time:
CELG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELG alerts
High impacting CELGENE news events
Weekly update
A roundup of the hottest topics